Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Recombinant Human Glial Cell Maturation Factor β Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Recombinant Human Glial Cell Maturation Factor β Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Devices & Consumables

Published Date: 2026-03-11

Pages: 106 Pages

Report ld: 6161262

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Recombinant Human Glial Cell Maturation Factor β Market Size(US$)

CAGR 2026-2032

6.5%

Market Size,2032

USD 168

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 115 million

Market Forecast in 2032(Value)

US$ 168 million

CAGR

6.5%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Recombinant Human Glial Cell Maturation Factor β market size was US$ 109 million in 2025 and is forecast to reach a readjusted size of US$ 168 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.

GMF-beta belongs to the actin-binding ADF/cofilin family of proteins. It contains an ADF-H domain, but crystallographic and NMR studies have shown structural differences between the human and mouse ADF-H domains. It was originally identified as a growth gamma differentiation factor acting on neurons and glial cells. It has also been shown to function intracellularly as a regulator of MAP kinase signaling.

In 2025, the North America Recombinant Human Glial Cell Maturation Factor β market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

Major global manufacturers of Recombinant Human Glial Cell Maturation Factor β include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Recombinant Human Glial Cell Maturation Factor β market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
Abbkine
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
ENZO

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity＜95%
Purity ≥95%

Segment by Application

University
Research Center

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term

Chapter 2: Quantitative analysis of Recombinant Human Glial Cell Maturation Factor β sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region

Chapter 3: Competitive landscape of Recombinant Human Glial Cell Maturation Factor β manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)

Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments

Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets

Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)

Chapter 7: Key manufacturer profiles –company overview, Recombinant Human Glial Cell Maturation Factor β product descriptions and specifications, revenue, gross margins, and recent developments

Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors

Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces

Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies

Chapter 11: Key findings, main takeaways, and overall conclusions of the report.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Recombinant Human Glial Cell Maturation Factor β value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Recombinant Human Glial Cell Maturation Factor β Product Scope

1.2 Recombinant Human Glial Cell Maturation Factor β by Type

1.2.1 Global Recombinant Human Glial Cell Maturation Factor β Sales by Type (2021, 2025 & 2032)

1.2.2 Purity＜95%

1.2.3 Purity ≥95%

1.3 Recombinant Human Glial Cell Maturation Factor β by Application

1.3.1 Global Recombinant Human Glial Cell Maturation Factor β Sales Comparison by Application (2021, 2025 & 2032)

1.3.2 University

1.3.3 Research Center

1.4 Global Recombinant Human Glial Cell Maturation Factor β Market Estimates and Forecasts (2021-2032)

1.4.1 Global Recombinant Human Glial Cell Maturation Factor β Market Size (Value) and Growth Rate (2021-2032)

1.4.2 Global Recombinant Human Glial Cell Maturation Factor β Market Size (Volume) and Growth Rate (2021-2032)

1.4.3 Global Recombinant Human Glial Cell Maturation Factor β Price Trends (2021-2032)

1.5 Assumptions and Limitations

2 Market Size and Prospects by Region

2.1 Global Recombinant Human Glial Cell Maturation Factor β Market Size by Region: 2021 VS 2025 VS 2032

2.2 Global Recombinant Human Glial Cell Maturation Factor β Historical Market Scenario by Region (2021-2026)

2.2.1 Global Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Region (2021-2026)

2.2.2 Global Recombinant Human Glial Cell Maturation Factor β Revenue Market Share by Region (2021-2026)

2.3 Global Recombinant Human Glial Cell Maturation Factor β Market Estimates and Forecasts by Region (2027-2032)

2.3.1 Global Recombinant Human Glial Cell Maturation Factor β Sales Estimates and Forecasts by Region (2027-2032)

2.3.2 Global Recombinant Human Glial Cell Maturation Factor β Revenue Forecast by Region (2027-2032)

2.4 Major Regions and Emerging Market Analysis

2.4.1 North America Recombinant Human Glial Cell Maturation Factor β Market Size and Prospects (2021-2032)

2.4.2 Europe Recombinant Human Glial Cell Maturation Factor β Market Size and Prospects (2021-2032)

2.4.3 China Recombinant Human Glial Cell Maturation Factor β Market Size and Prospects (2021-2032)

2.4.4 Japan Recombinant Human Glial Cell Maturation Factor β Market Size and Prospects (2021-2032)

3 Global Market Size by Type

3.1 Global Recombinant Human Glial Cell Maturation Factor β Historical Market Review by Type (2021-2026)

3.1.1 Global Recombinant Human Glial Cell Maturation Factor β Sales by Type (2021-2026)

3.1.2 Global Recombinant Human Glial Cell Maturation Factor β Revenue by Type (2021-2026)

3.1.3 Global Recombinant Human Glial Cell Maturation Factor β Average Price by Type (2021-2026)

3.2 Global Recombinant Human Glial Cell Maturation Factor β Market Estimates and Forecasts by Type (2027-2032)

3.2.1 Global Recombinant Human Glial Cell Maturation Factor β Sales Forecast by Type (2027-2032)

3.2.2 Global Recombinant Human Glial Cell Maturation Factor β Revenue Forecast by Type (2027-2032)

3.2.3 Global Recombinant Human Glial Cell Maturation Factor β Price Forecast by Type (2027-2032)

3.3 Representative Players for Different Types of Recombinant Human Glial Cell Maturation Factor β

4 Global Market Size by Application

4.1 Global Recombinant Human Glial Cell Maturation Factor β Historical Market Review by Application (2021-2026)

4.1.1 Global Recombinant Human Glial Cell Maturation Factor β Sales by Application (2021-2026)

4.1.2 Global Recombinant Human Glial Cell Maturation Factor β Revenue by Application (2021-2026)

4.1.3 Global Recombinant Human Glial Cell Maturation Factor β Average Price by Application (2021-2026)

4.2 Global Recombinant Human Glial Cell Maturation Factor β Market Estimates and Forecasts by Application (2027-2032)

4.2.1 Global Recombinant Human Glial Cell Maturation Factor β Sales Forecast by Application (2027-2032)

4.2.2 Global Recombinant Human Glial Cell Maturation Factor β Revenue Forecast by Application (2027-2032)

4.2.3 Global Recombinant Human Glial Cell Maturation Factor β Price Forecast by Application (2027-2032)

4.3 New Sources of Growth in Recombinant Human Glial Cell Maturation Factor β Applications

5 Competition Landscape by Players

5.1 Global Recombinant Human Glial Cell Maturation Factor β Sales by Player (2021-2026)

5.2 Global Top Recombinant Human Glial Cell Maturation Factor β Players by Revenue (2021-2026)

5.3 Global Recombinant Human Glial Cell Maturation Factor β Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Recombinant Human Glial Cell Maturation Factor β revenue as of 2025

5.4 Global Recombinant Human Glial Cell Maturation Factor β Average Price by Company (2021-2026)

5.5 Global Key Manufacturers of Recombinant Human Glial Cell Maturation Factor β, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Recombinant Human Glial Cell Maturation Factor β, Product Type & Application

5.7 Global Key Manufacturers of Recombinant Human Glial Cell Maturation Factor β, Date of Entry into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Regional Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Recombinant Human Glial Cell Maturation Factor β Sales by Company

6.1.1.1 North America Recombinant Human Glial Cell Maturation Factor β Sales by Company (2021-2026)

6.1.1.2 North America Recombinant Human Glial Cell Maturation Factor β Revenue by Company (2021-2026)

6.1.2 North America Recombinant Human Glial Cell Maturation Factor β Sales Breakdown by Type (2021-2026)

6.1.3 North America Recombinant Human Glial Cell Maturation Factor β Sales Breakdown by Application (2021-2026)

6.1.4 North America Recombinant Human Glial Cell Maturation Factor β Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Recombinant Human Glial Cell Maturation Factor β Sales by Company

6.2.1.1 Europe Recombinant Human Glial Cell Maturation Factor β Sales by Company (2021-2026)

6.2.1.2 Europe Recombinant Human Glial Cell Maturation Factor β Revenue by Company (2021-2026)

6.2.2 Europe Recombinant Human Glial Cell Maturation Factor β Sales Breakdown by Type (2021-2026)

6.2.3 Europe Recombinant Human Glial Cell Maturation Factor β Sales Breakdown by Application (2021-2026)

6.2.4 Europe Recombinant Human Glial Cell Maturation Factor β Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Recombinant Human Glial Cell Maturation Factor β Sales by Company

6.3.1.1 China Recombinant Human Glial Cell Maturation Factor β Sales by Company (2021-2026)

6.3.1.2 China Recombinant Human Glial Cell Maturation Factor β Revenue by Company (2021-2026)

6.3.2 China Recombinant Human Glial Cell Maturation Factor β Sales Breakdown by Type (2021-2026)

6.3.3 China Recombinant Human Glial Cell Maturation Factor β Sales Breakdown by Application (2021-2026)

6.3.4 China Recombinant Human Glial Cell Maturation Factor β Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Recombinant Human Glial Cell Maturation Factor β Sales by Company

6.4.1.1 Japan Recombinant Human Glial Cell Maturation Factor β Sales by Company (2021-2026)

6.4.1.2 Japan Recombinant Human Glial Cell Maturation Factor β Revenue by Company (2021-2026)

6.4.2 Japan Recombinant Human Glial Cell Maturation Factor β Sales Breakdown by Type (2021-2026)

6.4.3 Japan Recombinant Human Glial Cell Maturation Factor β Sales Breakdown by Application (2021-2026)

6.4.4 Japan Recombinant Human Glial Cell Maturation Factor β Major Customers

6.4.5 Japan Market Trends and Opportunities

7 Company Profiles and Key Figures

7.1 Thermo Fisher Scientific Inc.

7.1.1 Thermo Fisher Scientific Inc. Company Information

7.1.2 Thermo Fisher Scientific Inc. Business Overview

7.1.3 Thermo Fisher Scientific Inc. Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.1.4 Thermo Fisher Scientific Inc. Recombinant Human Glial Cell Maturation Factor β Products Offered

7.1.5 Thermo Fisher Scientific Inc. Recent Development

7.2 Bio-Techne

7.2.1 Bio-Techne Company Information

7.2.2 Bio-Techne Business Overview

7.2.3 Bio-Techne Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.2.4 Bio-Techne Recombinant Human Glial Cell Maturation Factor β Products Offered

7.2.5 Bio-Techne Recent Development

7.3 Scientists Helping Scientists

7.3.1 Scientists Helping Scientists Company Information

7.3.2 Scientists Helping Scientists Business Overview

7.3.3 Scientists Helping Scientists Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.3.4 Scientists Helping Scientists Recombinant Human Glial Cell Maturation Factor β Products Offered

7.3.5 Scientists Helping Scientists Recent Development

7.4 Abcam Limited

7.4.1 Abcam Limited Company Information

7.4.2 Abcam Limited Business Overview

7.4.3 Abcam Limited Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.4.4 Abcam Limited Recombinant Human Glial Cell Maturation Factor β Products Offered

7.4.5 Abcam Limited Recent Development

7.5 FUJIFILM Irvine Scientific

7.5.1 FUJIFILM Irvine Scientific Company Information

7.5.2 FUJIFILM Irvine Scientific Business Overview

7.5.3 FUJIFILM Irvine Scientific Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.5.4 FUJIFILM Irvine Scientific Recombinant Human Glial Cell Maturation Factor β Products Offered

7.5.5 FUJIFILM Irvine Scientific Recent Development

7.6 BD Biosciences

7.6.1 BD Biosciences Company Information

7.6.2 BD Biosciences Business Overview

7.6.3 BD Biosciences Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.6.4 BD Biosciences Recombinant Human Glial Cell Maturation Factor β Products Offered

7.6.5 BD Biosciences Recent Development

7.7 Bio-Rad Laboratories, Inc.

7.7.1 Bio-Rad Laboratories, Inc. Company Information

7.7.2 Bio-Rad Laboratories, Inc. Business Overview

7.7.3 Bio-Rad Laboratories, Inc. Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.7.4 Bio-Rad Laboratories, Inc. Recombinant Human Glial Cell Maturation Factor β Products Offered

7.7.5 Bio-Rad Laboratories, Inc. Recent Development

7.8 BPS Bioscience, Inc.

7.8.1 BPS Bioscience, Inc. Company Information

7.8.2 BPS Bioscience, Inc. Business Overview

7.8.3 BPS Bioscience, Inc. Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.8.4 BPS Bioscience, Inc. Recombinant Human Glial Cell Maturation Factor β Products Offered

7.8.5 BPS Bioscience, Inc. Recent Development

7.9 Elabscience

7.9.1 Elabscience Company Information

7.9.2 Elabscience Business Overview

7.9.3 Elabscience Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.9.4 Elabscience Recombinant Human Glial Cell Maturation Factor β Products Offered

7.9.5 Elabscience Recent Development

7.10 Yisheng Biotechnology (Shanghai) Co., Ltd.

7.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information

7.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview

7.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Products Offered

7.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development

7.11 Abbkine

7.11.1 Abbkine Company Information

7.11.2 Abbkine Business Overview

7.11.3 Abbkine Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.11.4 Abbkine Recombinant Human Glial Cell Maturation Factor β Products Offered

7.11.5 Abbkine Recent Development

7.12 Beijing Biocreative Technology Co., Ltd.

7.12.1 Beijing Biocreative Technology Co., Ltd. Company Information

7.12.2 Beijing Biocreative Technology Co., Ltd. Business Overview

7.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.12.4 Beijing Biocreative Technology Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Products Offered

7.12.5 Beijing Biocreative Technology Co., Ltd. Recent Development

7.13 Shanghai Yaji Biotechnology Co., Ltd.

7.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information

7.13.2 Shanghai Yaji Biotechnology Co., Ltd. Business Overview

7.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.13.4 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Products Offered

7.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Development

7.14 Cellverse Co., Ltd.

7.14.1 Cellverse Co., Ltd. Company Information

7.14.2 Cellverse Co., Ltd. Business Overview

7.14.3 Cellverse Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.14.4 Cellverse Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Products Offered

7.14.5 Cellverse Co., Ltd. Recent Development

7.15 Dalian Meilun Biotech Co., Ltd.

7.15.1 Dalian Meilun Biotech Co., Ltd. Company Information

7.15.2 Dalian Meilun Biotech Co., Ltd. Business Overview

7.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.15.4 Dalian Meilun Biotech Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Products Offered

7.15.5 Dalian Meilun Biotech Co., Ltd. Recent Development

7.16 Sino Biological,Inc.

7.16.1 Sino Biological,Inc. Company Information

7.16.2 Sino Biological,Inc. Business Overview

7.16.3 Sino Biological,Inc. Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.16.4 Sino Biological,Inc. Recombinant Human Glial Cell Maturation Factor β Products Offered

7.16.5 Sino Biological,Inc. Recent Development

7.17 Prospec-Tany Technogene Ltd

7.17.1 Prospec-Tany Technogene Ltd Company Information

7.17.2 Prospec-Tany Technogene Ltd Business Overview

7.17.3 Prospec-Tany Technogene Ltd Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.17.4 Prospec-Tany Technogene Ltd Recombinant Human Glial Cell Maturation Factor β Products Offered

7.17.5 Prospec-Tany Technogene Ltd Recent Development

7.18 ENZO

7.18.1 ENZO Company Information

7.18.2 ENZO Business Overview

7.18.3 ENZO Recombinant Human Glial Cell Maturation Factor β Sales, Revenue and Gross Margin (2021-2026)

7.18.4 ENZO Recombinant Human Glial Cell Maturation Factor β Products Offered

7.18.5 ENZO Recent Development

8 Recombinant Human Glial Cell Maturation Factor β Manufacturing Cost Analysis

8.1 Recombinant Human Glial Cell Maturation Factor β Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Recombinant Human Glial Cell Maturation Factor β

8.4 Recombinant Human Glial Cell Maturation Factor β Industrial Chain Analysis

9 Marketing Channels, Distributors and Customers

9.1 Marketing Channels

9.2 Recombinant Human Glial Cell Maturation Factor β Distributors List

9.3 Recombinant Human Glial Cell Maturation Factor β Customers

10 Recombinant Human Glial Cell Maturation Factor β Market Dynamics

10.1 Recombinant Human Glial Cell Maturation Factor β Industry Trends

10.2 Recombinant Human Glial Cell Maturation Factor β Market Drivers

10.3 Recombinant Human Glial Cell Maturation Factor β Market Challenges

10.4 Recombinant Human Glial Cell Maturation Factor β Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Recombinant Human Glial Cell Maturation Factor β Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)

Table 2. Global Recombinant Human Glial Cell Maturation Factor β Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)

Table 3. Global Market Recombinant Human Glial Cell Maturation Factor β Market Size (US$ Million) by Region:2021 VS 2025 VS 2032

Table 4. Global Recombinant Human Glial Cell Maturation Factor β Sales (K Units) by Region (2021-2026)

Table 5. Global Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Region (2021-2026)

Table 6. Global Recombinant Human Glial Cell Maturation Factor β Revenue (US$ Million) Market Share by Region (2021-2026)

Table 7. Global Recombinant Human Glial Cell Maturation Factor β Revenue Share by Region (2021-2026)

Table 8. Global Recombinant Human Glial Cell Maturation Factor β Sales (K Units) Forecast by Region (2027-2032)

Table 9. Global Recombinant Human Glial Cell Maturation Factor β Sales Market Share Forecast by Region (2027-2032)

Table 10. Global Recombinant Human Glial Cell Maturation Factor β Revenue (US$ Million) Forecast by Region (2027-2032)

Table 11. Global Recombinant Human Glial Cell Maturation Factor β Revenue Share Forecast by Region (2027-2032)

Table 12. Global Recombinant Human Glial Cell Maturation Factor β Sales by Type (K Units) & (2021-2026)

Table 13. Global Recombinant Human Glial Cell Maturation Factor β Sales Share by Type (2021-2026)

Table 14. Global Recombinant Human Glial Cell Maturation Factor β Revenue by Type (US$ Million) & (2021-2026)

Table 15. Global Recombinant Human Glial Cell Maturation Factor β Average Price by Type (US$/Unit) & (2021-2026)

Table 16. Global Recombinant Human Glial Cell Maturation Factor β Sales by Type (K Units) & (2027-2032)

Table 17. Global Recombinant Human Glial Cell Maturation Factor β Revenue by Type (US$ Million) & (2027-2032)

Table 18. Global Recombinant Human Glial Cell Maturation Factor β Average Price by Type (US$/Unit) & (2027-2032)

Table 19. Representative Players of Each Type

Table 20. Global Recombinant Human Glial Cell Maturation Factor β Sales by Application (K Units) & (2021-2026)

Table 21. Global Recombinant Human Glial Cell Maturation Factor β Sales Share by Application (2021-2026)

Table 22. Global Recombinant Human Glial Cell Maturation Factor β Revenue by Application (US$ Million) & (2021-2026)

Table 23. Global Recombinant Human Glial Cell Maturation Factor β Average Price by Application (US$/Unit) & (2021-2026)

Table 24. Global Recombinant Human Glial Cell Maturation Factor β Sales by Application (K Units) & (2027-2032)

Table 25. Global Recombinant Human Glial Cell Maturation Factor β Revenue Market Share by Application (US$ Million) & (2027-2032)

Table 26. Global Recombinant Human Glial Cell Maturation Factor β Average Price by Application (US$/Unit) & (2027-2032)

Table 27. New Sources of Growth in Recombinant Human Glial Cell Maturation Factor β Applications

Table 28. Global Recombinant Human Glial Cell Maturation Factor β Sales by Company (K Units) & (2021-2026)

Table 29. Global Recombinant Human Glial Cell Maturation Factor β Sales Share by Company (2021-2026)

Table 30. Global Recombinant Human Glial Cell Maturation Factor β Revenue by Company (US$ Million) & (2021-2026)

Table 31. Global Recombinant Human Glial Cell Maturation Factor β Revenue Share by Company (2021-2026)

Table 32. Global Recombinant Human Glial Cell Maturation Factor β by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Glial Cell Maturation Factor β as of 2025)

Table 33. Global Market Recombinant Human Glial Cell Maturation Factor β Average Price by Company (US$/Unit) & (2021-2026)

Table 34. Global Key Manufacturers of Recombinant Human Glial Cell Maturation Factor β, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Recombinant Human Glial Cell Maturation Factor β, Product Type & Application

Table 36. Global Key Manufacturers of Recombinant Human Glial Cell Maturation Factor β, Date of Entry into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Recombinant Human Glial Cell Maturation Factor β Sales by Company (2021-2026) & (K Units)

Table 39. North America Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Company (2021-2026)

Table 40. North America Recombinant Human Glial Cell Maturation Factor β Revenue by Company (2021-2026) & (US$ Million)

Table 41. North America Recombinant Human Glial Cell Maturation Factor β Revenue Market Share by Company (2021-2026)

Table 42. North America Recombinant Human Glial Cell Maturation Factor β Sales by Type (2021-2026) & (K Units)

Table 43. North America Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Type (2021-2026)

Table 44. North America Recombinant Human Glial Cell Maturation Factor β Sales by Application (2021-2026) & (K Units)

Table 45. North America Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Application (2021-2026)

Table 46. Europe Recombinant Human Glial Cell Maturation Factor β Sales by Company (2021-2026) & (K Units)

Table 47. Europe Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Company (2021-2026)

Table 48. Europe Recombinant Human Glial Cell Maturation Factor β Revenue by Company (2021-2026) & (US$ Million)

Table 49. Europe Recombinant Human Glial Cell Maturation Factor β Revenue Market Share by Company (2021-2026)

Table 50. Europe Recombinant Human Glial Cell Maturation Factor β Sales by Type (2021-2026) & (K Units)

Table 51. Europe Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Type (2021-2026)

Table 52. Europe Recombinant Human Glial Cell Maturation Factor β Sales by Application (2021-2026) & (K Units)

Table 53. Europe Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Application (2021-2026)

Table 54. China Recombinant Human Glial Cell Maturation Factor β Sales by Company (2021-2026) & (K Units)

Table 55. China Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Company (2021-2026)

Table 56. China Recombinant Human Glial Cell Maturation Factor β Revenue by Company (2021-2026) & (US$ Million)

Table 57. China Recombinant Human Glial Cell Maturation Factor β Revenue Market Share by Company (2021-2026)

Table 58. China Recombinant Human Glial Cell Maturation Factor β Sales by Type (2021-2026) & (K Units)

Table 59. China Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Type (2021-2026)

Table 60. China Recombinant Human Glial Cell Maturation Factor β Sales by Application (2021-2026) & (K Units)

Table 61. China Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Application (2021-2026)

Table 62. Japan Recombinant Human Glial Cell Maturation Factor β Sales by Company (2021-2026) & (K Units)

Table 63. Japan Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Company (2021-2026)

Table 64. Japan Recombinant Human Glial Cell Maturation Factor β Revenue by Company (2021-2026) & (US$ Million)

Table 65. Japan Recombinant Human Glial Cell Maturation Factor β Revenue Market Share by Company (2021-2026)

Table 66. Japan Recombinant Human Glial Cell Maturation Factor β Sales by Type (2021-2026) & (K Units)

Table 67. Japan Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Type (2021-2026)

Table 68. Japan Recombinant Human Glial Cell Maturation Factor β Sales by Application (2021-2026) & (K Units)

Table 69. Japan Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Application (2021-2026)

Table 70. Thermo Fisher Scientific Inc. Company Information

Table 71. Thermo Fisher Scientific Inc. Description and Business Overview

Table 72. Thermo Fisher Scientific Inc. Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 73. Thermo Fisher Scientific Inc. Recombinant Human Glial Cell Maturation Factor β Product

Table 74. Thermo Fisher Scientific Inc. Recent Development

Table 75. Bio-Techne Company Information

Table 76. Bio-Techne Description and Business Overview

Table 77. Bio-Techne Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 78. Bio-Techne Recombinant Human Glial Cell Maturation Factor β Product

Table 79. Bio-Techne Recent Development

Table 80. Scientists Helping Scientists Company Information

Table 81. Scientists Helping Scientists Description and Business Overview

Table 82. Scientists Helping Scientists Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 83. Scientists Helping Scientists Recombinant Human Glial Cell Maturation Factor β Product

Table 84. Scientists Helping Scientists Recent Development

Table 85. Abcam Limited Company Information

Table 86. Abcam Limited Description and Business Overview

Table 87. Abcam Limited Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 88. Abcam Limited Recombinant Human Glial Cell Maturation Factor β Product

Table 89. Abcam Limited Recent Development

Table 90. FUJIFILM Irvine Scientific Company Information

Table 91. FUJIFILM Irvine Scientific Description and Business Overview

Table 92. FUJIFILM Irvine Scientific Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 93. FUJIFILM Irvine Scientific Recombinant Human Glial Cell Maturation Factor β Product

Table 94. FUJIFILM Irvine Scientific Recent Development

Table 95. BD Biosciences Company Information

Table 96. BD Biosciences Description and Business Overview

Table 97. BD Biosciences Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 98. BD Biosciences Recombinant Human Glial Cell Maturation Factor β Product

Table 99. BD Biosciences Recent Development

Table 100. Bio-Rad Laboratories, Inc. Company Information

Table 101. Bio-Rad Laboratories, Inc. Description and Business Overview

Table 102. Bio-Rad Laboratories, Inc. Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 103. Bio-Rad Laboratories, Inc. Recombinant Human Glial Cell Maturation Factor β Product

Table 104. Bio-Rad Laboratories, Inc. Recent Development

Table 105. BPS Bioscience, Inc. Company Information

Table 106. BPS Bioscience, Inc. Description and Business Overview

Table 107. BPS Bioscience, Inc. Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 108. BPS Bioscience, Inc. Recombinant Human Glial Cell Maturation Factor β Product

Table 109. BPS Bioscience, Inc. Recent Development

Table 110. Elabscience Company Information

Table 111. Elabscience Description and Business Overview

Table 112. Elabscience Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 113. Elabscience Recombinant Human Glial Cell Maturation Factor β Product

Table 114. Elabscience Recent Development

Table 115. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information

Table 116. Yisheng Biotechnology (Shanghai) Co., Ltd. Description and Business Overview

Table 117. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 118. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Product

Table 119. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development

Table 120. Abbkine Company Information

Table 121. Abbkine Description and Business Overview

Table 122. Abbkine Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 123. Abbkine Recombinant Human Glial Cell Maturation Factor β Product

Table 124. Abbkine Recent Development

Table 125. Beijing Biocreative Technology Co., Ltd. Company Information

Table 126. Beijing Biocreative Technology Co., Ltd. Description and Business Overview

Table 127. Beijing Biocreative Technology Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 128. Beijing Biocreative Technology Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Product

Table 129. Beijing Biocreative Technology Co., Ltd. Recent Development

Table 130. Shanghai Yaji Biotechnology Co., Ltd. Company Information

Table 131. Shanghai Yaji Biotechnology Co., Ltd. Description and Business Overview

Table 132. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 133. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Product

Table 134. Shanghai Yaji Biotechnology Co., Ltd. Recent Development

Table 135. Cellverse Co., Ltd. Company Information

Table 136. Cellverse Co., Ltd. Description and Business Overview

Table 137. Cellverse Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 138. Cellverse Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Product

Table 139. Cellverse Co., Ltd. Recent Development

Table 140. Dalian Meilun Biotech Co., Ltd. Company Information

Table 141. Dalian Meilun Biotech Co., Ltd. Description and Business Overview

Table 142. Dalian Meilun Biotech Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 143. Dalian Meilun Biotech Co., Ltd. Recombinant Human Glial Cell Maturation Factor β Product

Table 144. Dalian Meilun Biotech Co., Ltd. Recent Development

Table 145. Sino Biological,Inc. Company Information

Table 146. Sino Biological,Inc. Description and Business Overview

Table 147. Sino Biological,Inc. Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 148. Sino Biological,Inc. Recombinant Human Glial Cell Maturation Factor β Product

Table 149. Sino Biological,Inc. Recent Development

Table 150. Prospec-Tany Technogene Ltd Company Information

Table 151. Prospec-Tany Technogene Ltd Description and Business Overview

Table 152. Prospec-Tany Technogene Ltd Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 153. Prospec-Tany Technogene Ltd Recombinant Human Glial Cell Maturation Factor β Product

Table 154. Prospec-Tany Technogene Ltd Recent Development

Table 155. ENZO Company Information

Table 156. ENZO Description and Business Overview

Table 157. ENZO Recombinant Human Glial Cell Maturation Factor β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 158. ENZO Recombinant Human Glial Cell Maturation Factor β Product

Table 159. ENZO Recent Development

Table 160. Production Base and Market Concentration Rate of Raw Material

Table 161. Key Suppliers of Raw Materials

Table 162. Recombinant Human Glial Cell Maturation Factor β Distributors List

Table 163. Recombinant Human Glial Cell Maturation Factor β Customers List

Table 164. Recombinant Human Glial Cell Maturation Factor β Market Trends

Table 165. Recombinant Human Glial Cell Maturation Factor β Market Drivers

Table 166. Recombinant Human Glial Cell Maturation Factor β Market Challenges

Table 167. Recombinant Human Glial Cell Maturation Factor β Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Recombinant Human Glial Cell Maturation Factor β Product Picture

Figure 2. Global Recombinant Human Glial Cell Maturation Factor β Sales (US$ Million) by Type (2021, 2025 & 2032)

Figure 3. Global Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Type in 2025 & 2032

Figure 4. Purity＜95% Product Picture

Figure 5. Purity ≥95% Product Picture

Figure 6. Global Recombinant Human Glial Cell Maturation Factor β Sales (US$ Million) by Application (2021, 2025 & 2032)

Figure 7. Global Recombinant Human Glial Cell Maturation Factor β Sales Market Share by Application in 2025 & 2032

Figure 8. University Examples

Figure 9. Research Center Examples

Figure 10. Global Recombinant Human Glial Cell Maturation Factor β Sales, (US$ Million), 2021 VS 2025 VS 2032

Figure 11. Global Recombinant Human Glial Cell Maturation Factor β Sales Growth Rate (2021-2032) & (US$ Million)

Figure 12. Global Recombinant Human Glial Cell Maturation Factor β Sales (K Units) Growth Rate (2021-2032)

Figure 13. Global Recombinant Human Glial Cell Maturation Factor β Price Trends Growth Rate (2021-2032) & (US$/Unit)

Figure 14. Recombinant Human Glial Cell Maturation Factor β Report Years Considered

Figure 15. Global Market Recombinant Human Glial Cell Maturation Factor β Market Size (US$ Million) by Region:2021 VS 2025 VS 2032

Figure 16. Global Recombinant Human Glial Cell Maturation Factor β Revenue Market Share by Region: 2021 VS 2025

Figure 17. North America Recombinant Human Glial Cell Maturation Factor β Revenue (US$ Million) Growth Rate (2021-2032)

Figure 18. North America Recombinant Human Glial Cell Maturation Factor β Sales (K Units) Growth Rate (2021-2032)

Figure 19. Europe Recombinant Human Glial Cell Maturation Factor β Revenue (US$ Million) Growth Rate (2021-2032)

Figure 20. Europe Recombinant Human Glial Cell Maturation Factor β Sales (K Units) Growth Rate (2021-2032)

Figure 21. China Recombinant Human Glial Cell Maturation Factor β Revenue (US$ Million) Growth Rate (2021-2032)

Figure 22. China Recombinant Human Glial Cell Maturation Factor β Sales (K Units) Growth Rate (2021-2032)

Figure 23. Japan Recombinant Human Glial Cell Maturation Factor β Revenue (US$ Million) Growth Rate (2021-2032)

Figure 24. Japan Recombinant Human Glial Cell Maturation Factor β Sales (K Units) Growth Rate (2021-2032)

Figure 25. Global Recombinant Human Glial Cell Maturation Factor β Revenue Share by Type (2021-2026)

Figure 26. Global Recombinant Human Glial Cell Maturation Factor β Sales Share by Type (2027-2032)

Figure 27. Global Recombinant Human Glial Cell Maturation Factor β Revenue Share by Type (2027-2032)

Figure 28. Global Recombinant Human Glial Cell Maturation Factor β Revenue Share by Application (2021-2026)

Figure 29. Global Recombinant Human Glial Cell Maturation Factor β Revenue Market Share by Application in 2021 & 2025

Figure 30. Global Recombinant Human Glial Cell Maturation Factor β Sales Share by Application (2027-2032)

Figure 31. Global Recombinant Human Glial Cell Maturation Factor β Revenue Share by Application (2027-2032)

Figure 32. Global Recombinant Human Glial Cell Maturation Factor β Sales Share by Company (2025)

Figure 33. Global Recombinant Human Glial Cell Maturation Factor β Revenue Share by Company (2025)

Figure 34. Global 5 Largest Recombinant Human Glial Cell Maturation Factor β Players Market Share by Revenue in Recombinant Human Glial Cell Maturation Factor β: 2021 & 2025

Figure 35. Recombinant Human Glial Cell Maturation Factor β Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025

Figure 36. Manufacturing Cost Structure of Recombinant Human Glial Cell Maturation Factor β

Figure 37. Manufacturing Process Analysis of Recombinant Human Glial Cell Maturation Factor β

Figure 38. Recombinant Human Glial Cell Maturation Factor β Industrial Chain

Figure 39. Channels of Distribution (Direct Vs Distribution)

Figure 40. Distributors Profiles

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Recombinant Human Glial Cell Maturation Factor β in 2026? zhanKai

The global market size of Recombinant Human Glial Cell Maturation Factor β in 2026 was 115 Million USD.

What was the global market size of Recombinant Human Glial Cell Maturation Factor β in 2032? shouQi

What is the annual compound growth rate of the global Recombinant Human Glial Cell Maturation Factor β market size from 2026 to 2032? shouQi

Which companies rank high in the global Recombinant Human Glial Cell Maturation Factor β market? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Recombinant Human Glial Cell Maturation Factor β Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Human Glial Cell Maturation Factor β market is projected to grow from US$ 109 million in 2025 to US$ 168 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 172
USD 4900.00
(Single User License)
Global Recombinant Human Glial Cell Maturation Factor β Market Research Report 2026
The global Recombinant Human Glial Cell Maturation Factor β market was valued at US$ 109 million in 2025 and is anticipated to reach US$ 168 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 135
USD 2900.00
(Single User License)
Recombinant Human Glial Cell Maturation Factor β- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Recombinant Human Glial Cell Maturation Factor β was estimated to be worth US$ 109 million in 2025 and is projected to reach US$ 168 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 147
USD 3950.00
(Single User License)
Global Recombinant Human Glial Cell Maturation Factor β Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Human Glial Cell Maturation Factor β market size was US$ 104 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 105
USD 4250.00
(Single User License)
Global Recombinant Human Glial Cell Maturation Factor β Market Research Report 2025
The global market for Recombinant Human Glial Cell Maturation Factor β was valued at US$ 104 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-04-13
Pages: 103
USD 2900.00
(Single User License)
Recombinant Human Glial Cell Maturation Factor β - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Human Glial Cell Maturation Factor β was estimated to be worth US$ 104 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 149
USD 3950.00
(Single User License)
Global Recombinant Human Glial Cell Maturation Factor β Market Insights, Forecast to 2031
The global Recombinant Human Glial Cell Maturation Factor β market is projected to grow from US$ 109 million in 2025 to US$ 159 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Published Date: 2025-04-13
Pages: 166
USD 4900.00
(Single User License)

Global Recombinant Human Glial Cell Maturation Factor β Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Human Glial Cell Maturation Factor β market is projected to grow from US$ 109 million in 2025 to US$ 168 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 172
USD 4900.00 (Single User License)
Global Recombinant Human Glial Cell Maturation Factor β Market Research Report 2026
The global Recombinant Human Glial Cell Maturation Factor β market was valued at US$ 109 million in 2025 and is anticipated to reach US$ 168 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-03-11
Pages: 135
USD 2900.00 (Single User License)
Recombinant Human Glial Cell Maturation Factor β- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Recombinant Human Glial Cell Maturation Factor β was estimated to be worth US$ 109 million in 2025 and is projected to reach US$ 168 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-03-09
Pages: 147
USD 3950.00 (Single User License)
Global Recombinant Human Glial Cell Maturation Factor β Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Human Glial Cell Maturation Factor β market size was US$ 104 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 105
USD 4250.00 (Single User License)
Global Recombinant Human Glial Cell Maturation Factor β Market Research Report 2025
The global market for Recombinant Human Glial Cell Maturation Factor β was valued at US$ 104 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-04-13
Pages: 103
USD 2900.00 (Single User License)
Recombinant Human Glial Cell Maturation Factor β - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Human Glial Cell Maturation Factor β was estimated to be worth US$ 104 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 149
USD 3950.00 (Single User License)
Global Recombinant Human Glial Cell Maturation Factor β Market Insights, Forecast to 2031
The global Recombinant Human Glial Cell Maturation Factor β market is projected to grow from US$ 109 million in 2025 to US$ 159 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Published: 2025-04-13
Pages: 166
USD 4900.00 (Single User License)